Korean Pharma Accelerates Coronavirus-Related R&D, Calls For More Support
As South Korean companies jump into the development of vaccines and drugs for the coronavirus, they also call for stronger government support and increased collaboration between the state and private sectors.
You may also be interested in...
Celltrion unveils emergency plans to deal with the COVID-19 situation in South Korea by speeding up development of a potential therapeutic antibody and rapid, accurate testing kit without considering economic returns.
If clinical trials prove it effective against COVID-19, remdesivir could potentially help millions of patients - which raises big questions about funding and access.
Komipharm files for emergency clinical trial of its investigative drug to treat coronavirus pneumonia, which is poised to become the first such study by a Korean company.